Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study

Conclusions: These results suggest that the use of ROF in standard clinical practice may reduce the frequency of COPD exacerbations.

Source: European Respiratory Journal - December 6, 2017 Category: Respiratory Medicine Authors: Vogelmeier, C., Tzanakis, N., Lassan, S., Genofre, E., Ding, B., Horton, J., Bakke, P. Tags: Clinical Problems COPD Source Type: research